2023
DOI: 10.1007/s40801-023-00394-y
|View full text |Cite
|
Sign up to set email alerts
|

Impact of Risk Minimisation Measures on Valproate Use among Women of Reproductive Age in Latvia Between 2013 and 2020: A 7-Year Nationwide Prescription Database Study

Ieva Rutkovska,
Andis Seilis,
Zane Neikena
et al.

Abstract: Background A relevant safety concern for the use of valproate (VPA) in women of reproductive age is its teratogenicity. In 2014 European Medicines Agency (EMA) introduced risk minimisation measures (RMMs) to reduce the VPA use by women of reproductive age, where the impact on VPA use was not as large as expected. In 2018, the EMA introduced additional RMMs, and it is essential to assess impact of these interventions. Objective The objective of this study was to evaluate… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 23 publications
0
1
0
Order By: Relevance
“…According to local data protection regulations, no approval from the ethics committee was required for this study. 43 , 44 …”
Section: Methodsmentioning
confidence: 99%
“…According to local data protection regulations, no approval from the ethics committee was required for this study. 43 , 44 …”
Section: Methodsmentioning
confidence: 99%